Reversibility of hepatic failure following jejunoileal bypass.
Jejunoileal bypass was performed in 50 morbidly obeses patients. The morbidity encountered compared favorably with that of other series. All patients manifesting hepatic failure demonstrated hyperbilirubinemia within the first three months postoperatively. Hyperbilirubinemia, if uncorrected, resulted in a mortality of 75%. Augmentation jejunal interposition was performed in three patients who demonstrated hepatic decompensation or severe electrolyte imbalance or both. This resulted in rapid correction of electrolyte disturbances, liver function measurements, and patient symptoms without significant postoperative weight gain. Persistent hyperbilirubinemia or recalcitrant electrolyte problems or both are indications for augmentation jejunal interposition.
D001835:Body Weight; D002140:California; D002763:Cholecystectomy; D002769:Cholelithiasis / Q000209:etiology / Q000601:surgery; D006501:Hepatic Encephalopathy / Q000601:surgery*; D006801:Humans; D006932:Hyperbilirubinemia / Q000401:mortality / Q000601:surgery; D007082:Ileum / Q000601:surgery*; D007583:Jejunum / Q000601:surgery*; D009765:Obesity / Q000628:therapy; D011183:Postoperative Complications / Q000601:surgery*